Regeneron Pharmaceuticals Inc (REGN)

Days of inventory on hand (DOH)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Inventory turnover		1.04	1.03	1.06	1.08	1.10	0.75	0.75	0.71	0.65	0.98	1.02	1.17	1.17	0.88	0.83	0.66	0.73	0.95	1.10	1.27
DOH	days	349.51	354.33	345.59	338.41	331.61	484.22	489.44	516.47	561.08	371.81	356.36	311.79	311.42	416.23	440.41	549.49	499.83	385.30	332.13	288.13

December 31, 2024 calculation

DOH = 365 ÷ Inventory turnover
= 365 ÷ 1.04
= 349.51

The days of inventory on hand (DOH) for Regeneron Pharmaceuticals Inc have shown fluctuations over the period from March 31, 2020, to December 31, 2024.

DOH increased steadily from 288.13 days as of March 31, 2020, to a peak of 561.08 days by December 31, 2022. This significant increase indicates the company may have been holding excess inventory relative to its sales during this period, which could tie up working capital and lead to potential obsolescence or carrying costs.

Subsequently, there was a notable decrease in DOH to 331.61 days by December 31, 2023, which suggests that Regeneron may have implemented inventory management strategies to reduce the level of inventory on hand.

The DOH continued to decline slightly to 349.51 days by December 31, 2024, indicating that the company may still be fine-tuning its inventory levels.

Overall, monitoring changes in the days of inventory on hand is crucial for evaluating how efficiently Regeneron Pharmaceuticals Inc manages its inventory and controls related costs. A lower DOH generally signifies improved inventory management, whereas a higher DOH could indicate potential risks related to excess or slow-moving inventory.